• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW ORTHOPAEDICS LTD HEMI HEAD 50MM; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW ORTHOPAEDICS LTD HEMI HEAD 50MM; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING Back to Search Results
Catalog Number 74122550
Device Problems Insufficient Information (3190); Appropriate Term/Code Not Available (3191)
Patient Problems Pain (1994); Toxicity (2333); Injury (2348)
Event Date 05/04/2018
Event Type  Injury  
Event Description
It was reported that right hip revision surgery was performed due to pain and elevated ion levels.
 
Manufacturer Narrative
It was reported that right hip revision surgery was performed.During the revision, the hemi head and modular sleeve were removed.The bhr cup and anthology stem remained implanted.As of today, device return and additional information has been requested for this complaint but has not become available.The part / lot details provided for the right side index was a copy of the devices used for the left side index implantation.Therefore, no details are available for right side, and a documentation review could not be completed.If more information is received, this investigation will be reopened.The available medical documents were reviewed.The reported intraoperative findings of elevated metal ion levels, fluid, and corrosion may be consistent with findings associated with metal debris.However, the patient¿s comorbidities, past pelvic fractures and history of radiation and multiple steroid injections post tha, cannot be excluded as a contributing factors which could affect bone quality and positioning.The root cause of the reported clinical symptoms cannot be confirmed, and it cannot be concluded that the reported reactions/events were associated with a mal-performance of the implant.Without return of the actual devices or further information we cannot further investigate or confirm the details supplied in this complaint, and our investigation remains inconclusive.If the products or additional information become available in the future, this case will be reopened.No preventative or corrective action has been initiated as a result of this investigation.Additional information: brand name and concomitant medical products.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEMI HEAD 50MM
Type of Device
PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING
Manufacturer (Section D)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house
spa park
leamington spa CV31 3HL
UK  CV31 3HL
MDR Report Key9217457
MDR Text Key163117021
Report Number3005975929-2019-00381
Device Sequence Number1
Product Code NXT
UDI-Device Identifier03596010502599
UDI-Public03596010502599
Combination Product (y/n)N
PMA/PMN Number
P040033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,other
Type of Report Initial,Followup
Report Date 12/02/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number74122550
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 10/11/2019
Initial Date FDA Received10/22/2019
Supplement Dates Manufacturer Received10/11/2019
Supplement Dates FDA Received12/02/2019
Patient Sequence Number1
Treatment
ACETLR CUP HAP 56MM 74120156/ UNKNOWN; ANTHOLOGY STEM 71356106/UNKNOWN; HEMI HEAD, # 74122550, LOT # 10303; MODULAR SLEEVE 74222300/ UNKNOWN; MODULAR SLEEVE, # 74222300, LOT # 9768; HEMI HEAD, # 74122550, LOT # 10303; MODULAR SLEEVE, # 74222300, LOT # 9768
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age54 YR
-
-